463 related articles for article (PubMed ID: 16896582)
1. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
[TBL] [Abstract][Full Text] [Related]
2. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
Berger R; Luescher D; Just M
Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
4. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
Breuer J; Schmid DS; Gershon AA
J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
[TBL] [Abstract][Full Text] [Related]
5. Varicella immunity in vaccinated healthcare workers.
Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
[TBL] [Abstract][Full Text] [Related]
6. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
Watson B
J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
[TBL] [Abstract][Full Text] [Related]
8. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
[TBL] [Abstract][Full Text] [Related]
9. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of children with malignant disease against varicella.
Slørdahl SH; Wiger D; Strømøy T; Degre M; Thørsby E; Lie SO
Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
[TBL] [Abstract][Full Text] [Related]
11. Varicella vaccination in HIV-1-infected children after immune reconstitution.
Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
[TBL] [Abstract][Full Text] [Related]
12. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
[TBL] [Abstract][Full Text] [Related]
13. Live varicella immunization in healthy non-immune nurses.
Ndumbe PM; Cradock-Watson JE; Heath RB; Levinsky RJ
Postgrad Med J; 1985; 61 Suppl 4():133-5. PubMed ID: 3014470
[TBL] [Abstract][Full Text] [Related]
14. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
[TBL] [Abstract][Full Text] [Related]
15. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
Grose C
Mol Biol Med; 1989 Oct; 6(5):453-62. PubMed ID: 2560525
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
[TBL] [Abstract][Full Text] [Related]
17. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
Berger R; Luescher D; Just M; D'Hondt E; Bogaert H
Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471
[TBL] [Abstract][Full Text] [Related]
18. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.
Frey CR; Sharp MA; Min AS; Schmid DS; Loparev V; Arvin AM
J Infect Dis; 2003 Jul; 188(1):40-52. PubMed ID: 12825169
[TBL] [Abstract][Full Text] [Related]
19. Immunity to varicella zoster virus in young Israeli adults.
Avrahami-Heller Y; Cohen D; Orr N; Slepon R; Ashkenazi I; Danon YL
Isr Med Assoc J; 2000 Mar; 2(3):196-9. PubMed ID: 10774265
[TBL] [Abstract][Full Text] [Related]
20. Varicella vaccination in children with steroid-sensitive nephrotic syndrome.
Alpay H; Yildiz N; Onar A; Temizer H; Ozçay S
Pediatr Nephrol; 2002 Mar; 17(3):181-3. PubMed ID: 11956856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]